Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

PurposeTo compare the efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy (PCV) over 96 weeks in the HAWK study.DesignHAWK was a global, 2-year, randomised, double-masked, multicentre phase III trial in participants with neovascular age-related macul...

Celý popis

Podrobná bibliografie

Vydáno v:	British journal of ophthalmology Ročník 106; číslo 7; s. 994 - 999
Hlavní autoři:	Ogura, Yuichiro, Jaffe, Glenn J, Cheung, Chui Ming Gemmy, Kokame, Gregg T, Iida, Tomohiro, Takahashi, Kanji, Lee, Won Ki, Chang, Andrew A, Monés, Jordi, D’Souza, Divya, Weissgerber, Georges, Gedif, Kinfemichael, Koh, Adrian
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	BMA House, Tavistock Square, London, WC1H 9JR BMJ Publishing Group Ltd 01.07.2022 BMJ Publishing Group LTD BMJ Publishing Group
Témata:	Clinical outcomes Clinical Science clinical trial Diabetic retinopathy Drug therapy Eye diseases Immunotherapy Monoclonal antibodies Patient safety retina Side effects Vein & artery diseases Japan
ISSN:	0007-1161, 1468-2079, 1468-2079
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!